FDA.reportPublic FDA data

{28 (drospirenone 0.25 MG / estradiol 0.5 MG Oral Tablet) } Pack [Angeliq 0.25/0.5 28 Day]

RxCUI
1483551
RxNorm name
{28 (drospirenone 0.25 MG / estradiol 0.5 MG Oral Tablet) } Pack [Angeliq 0.25/0.5 28 Day]
Display name
{28 (drospirenone 0.25 MG / estradiol 0.5 MG Oral Tablet) } Pack [Angeliq 0.25/0.5 28 Day]
Full name
{28 (drospirenone 0.25 MG / estradiol 0.5 MG Oral Tablet) } Pack [Angeliq 0.25/0.5 28 Day]
Term type
BPCK
Status
DailyMed mapping
Updated
2026-06-04 23:39:04

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AngeliqDROSPIRENONE AND ESTRADIOLBayer HealthCare Pharmaceuticals Inc.761834c2-6b61-4583-84c2-f1ca4a97c4f22026-03-02Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1483551

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
761834c2-6b61-4583-84c2-f1ca4a97c4f2{28 (drospirenone 0.25 MG / estradiol 0.5 MG Oral Tablet) } Pack [Angeliq 0.25/0.5 28 Day] [BPCK] · Angeliq 0.25/0.5 28 Day Pack [PSN] · Angeliq 0.25/0.5 28 Day Pack [SY]320These highlights do not include all the information needed to use ANGELIQ safely and effectively. See full prescribing information for ANGELIQ. ANGELIQ (drospirenone and estradiol) tablets, for oral use Initial U.S. Approval: 200520260302